Loading...
Although antiretroviral therapy (ART) has vastly improved quality of life and decreased mortality for HIV-infected individuals, patients often continue to have low levels of CD4 cells in lymphatic tissue.
Noting that drug-distribution studies in animal models of AIDS had shown antiretroviral (ARV) drug concentrations to differ between tissues and peripheral blood, investigators started 12 HIV-infected individuals on ART (tenofovir and FTC plus efavirenz, ritonavir-boosted atazanavir, or darunavir) and followed them for 6 months, taking samples of peripheral blood as well as lymph node, ileal, and rectal tissue. Before the study, 10 of the individuals had been ART naive, and the other 2 had been off ART for >1 year.
All participants achieved e…